about
Sézary Syndrome and Atopic Dermatitis: Comparison of Immunological Aspects and TargetsThe Long-Term Course of Atopic Dermatitis.Persistence of atopic dermatitis (AD): A systematic review and meta-analysis.Association Between Malignancy and Topical Use of Pimecrolimus.Atopic dermatitis disease control and age: A cohort study.Association of HLA-DRB1 genetic variants with the persistence of atopic dermatitis.Cutaneous Adverse Events in the Randomized, Double-Blind, Active-Comparator DECIDE Study of Daclizumab High-Yield Process Versus Intramuscular Interferon Beta-1a in Relapsing-Remitting Multiple SclerosisAwareness of Atopic Dermatitis and Attitudes toward Different Types of Medical Institutions for Its Treatment among Adult Patients and the Parents of Pediatric Patients: A Survey of 500 Participants.Dupilumab for the treatment of atopic dermatitis: A clinical trial review.Variations in risk of asthma and seasonal allergies between early- and late-onset pediatric atopic dermatitis: A cohort study.Burden of Atopic Dermatitis in the United States: Analysis of Healthcare Claims Data in the Commercial, Medicare, and Medi-Cal Databases.Atopic dermatitis is associated with anxiety, depression, and suicidal ideation, but not with psychiatric hospitalization or suicide.The immunology of atopic dermatitis and its reversibility with broad-spectrum and targeted therapies.An Italian multicentre study on adult atopic dermatitis: persistent versus adult-onset disease.Addressing treatment challenges in atopic dermatitis with novel topical therapies.Crisaborole and its potential role in treating atopic dermatitis: overview of early clinical studies.Atopic Dermatitis in Israeli Adolescents from 1998 to 2013: Trends in Time and Association with Migraine.Skin absorption through atopic dermatitis skin: a systematic review.Dupilumab in the treatment of moderate-to-severe atopic dermatitis.Prevalence of comorbidity and associated risk factors in adults with atopic dermatitis.Frequency and Management of Sleep Disturbance in Adults with Atopic Dermatitis: A Systematic ReviewDomestic dog exposure at birth reduces the incidence of atopic dermatitis.The Burden of Atopic Dermatitis in U.S. Adults: Results from the 2013 National Health and Wellness Survey.Association between atopic dermatitis and attention deficit hyperactivity disorder in U.S. children and adults.Cross-sectional comparisons of patient-reported disease control, disease severity and symptom frequency in children with atopic dermatitis.A clinical trial of intradermal and intramuscular seasonal influenza vaccination in patients with atopic dermatitis.Health-related quality of life in adult dermatitis patients stratified by filaggrin genotype.Comorbidities of Atopic Dermatitis: Beyond Rhinitis and AsthmaThe atopic dermatitis blood signature is characterized by increases in inflammatory and cardiovascular risk proteins.Current Understanding in Pathogenesis of Atopic Dermatitis.The etiopathogenesis of atopic dermatitis: barrier disruption, immunological derangement, and pruritus.Economic value of using partially hydrolysed infant formula for risk reduction of atopic dermatitis in high-risk infants not exclusively breastfed in Singapore.Phenotypical Differences of Childhood- and Adult-Onset Atopic Dermatitis.Burden of atopic dermatitis in Japanese adults: Analysis of data from the 2013 National Health and Wellness Survey.Profile of dupilumab and its potential in the treatment of inadequately controlled moderate-to-severe atopic dermatitis.Increasing Adherence with Topical Agents for Atopic Dermatitis.First-in-human topical microbiome transplantation with Roseomonas mucosa for atopic dermatitis.Inflammatory skin disorders and self-esteem.
P2860
Q26746551-4B0A754D-6BB0-4B40-ABC7-8847E653AC81Q30234105-6CCB1659-9202-4CDB-9D42-FEECD3BB2CE6Q30248375-B3C848C2-3711-434F-93F8-8D2ADB1BCF02Q35733343-BE2BA2B0-BA1D-4861-9B93-B43214D48CC3Q35828352-66AA6FAE-21E8-45EB-980E-57D2895F1891Q36122531-DD5A0FF4-3D71-40DE-BED1-08B5524CC426Q37080630-39A7549E-47EC-4DCB-9467-5A7CB96D1583Q37446817-6BF8B964-BE47-4509-9523-9335F4BF833FQ38597397-2FC35CCC-4E06-414D-812F-E872B875CBF2Q38619479-F87F867B-5DF2-47E6-B89F-8CF65D01A664Q38679654-078D8F26-FC83-4092-8E9D-B81F5CC2B55FQ38717219-9D72F6D8-D1AD-41AD-9888-7928E62AE3E3Q38733182-397A5A23-CAC8-4DD2-9D90-99D08A4A0C9AQ38825683-95754BC7-B75E-4ECB-ABB7-1F888591E011Q38831401-3AA76B85-3177-4430-9B28-9A6E9F8FDAC8Q38860798-7E60CBB0-CD39-4974-A144-3DA7C696E6BEQ38894660-F87ADA57-FFE7-4BF9-864A-2795B1094CE6Q38957449-B9D4BB80-5C0E-4972-8694-1BC42C681AFFQ39122316-7DF09147-1DD5-40AE-B040-50973FF49682Q39172604-780FDDFA-3650-47A6-A202-950AEFFEE89EQ39434355-8762F135-5F94-40CC-ACD2-A27393E83787Q39625929-753380BA-F6D1-4462-97DB-951778093C9EQ39725517-39E30EBB-D025-44FE-8845-18F0DE86D7E1Q39829763-B5D04CD7-6A24-4293-B7A7-719E2BFE273DQ40319704-C10C285F-ABDB-481E-BBF8-F4585D85EAF0Q40329113-34E86187-0672-4BD8-9DF2-11624F613084Q40416597-94EE844C-F3FA-4434-B622-097A53CDF927Q41389046-3C81E1D5-E2F3-474E-85ED-0711376E9686Q41459873-73A82A5D-6A15-43D9-BF38-9EC5EA9BE267Q41823296-455B084B-A079-458F-81C8-435FF8F67D8AQ47144191-D1DA7C96-E9E0-4D20-8852-D7C436089086Q47353933-5BBBC502-80AC-479F-846F-1C2B748EC19AQ47615898-B3E7BF8B-10F0-4AB0-A7CC-24F062BE4E21Q47638497-CA1007BB-A73A-4635-B194-D44BD9A05ADCQ50129104-15FF5077-50CA-45E3-8503-1680432D0C9AQ50873336-325E67B1-EF9B-4FBE-A942-7E8FC73098C5Q53826618-2B38DFBA-879E-400C-A8F8-E87D42607738Q54961217-026F109A-C0C6-4AF7-9A9C-3F932735E5AC
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Persistence of mild to moderate atopic dermatitis.
@ast
Persistence of mild to moderate atopic dermatitis.
@en
type
label
Persistence of mild to moderate atopic dermatitis.
@ast
Persistence of mild to moderate atopic dermatitis.
@en
prefLabel
Persistence of mild to moderate atopic dermatitis.
@ast
Persistence of mild to moderate atopic dermatitis.
@en
P2093
P2860
P1433
P1476
Persistence of mild to moderate atopic dermatitis.
@en
P2093
David J Margolis
Jacob S Margolis
Ole Hoffstad
Warren Bilker
P2860
P304
P356
10.1001/JAMADERMATOL.2013.10271
P407
P577
2014-06-01T00:00:00Z